ABSTRACT
This study aimed to analyze perioperative results in robot-assisted laparoscopic urological surgeries, comparing the AirSeal system with traditional pneumoperitoneum systems. This study adhered to the PRISMA guidelines for conducting systematic reviews and meta-analyses. Extensive searches were conducted in PubMed, EMBASE, and Google Scholar, including randomized controlled trials (RCTs) and cohort studies up to June 15, 2024. A combined examination of the studies found that the AirSeal system had superior results in terms of surgery duration, end-tidal carbon dioxide levels, and tidal volume compared to the traditional pneumoperitoneum system. During robotic-assisted partial nephrectomy, the AirSeal team experienced a notable decrease in surgical time, ETCO2, and VT. In addition, the occurrence of SCE was lower in the AirSeal group. However, there were no significant differences observed between the groups regarding EBL, LOHS, overall complications, and major complications. Compared to conventional pneumoperitoneum systems, the AirSeal system offers several advantages in robot-assisted laparoscopic urological surgery: reduced operative time, lower end-tidal CO2 pressure, and decreased tidal volume. Furthermore, implementing the AirSeal system does not lead to higher rates of complications, estimated blood loss, or lengthier hospital stays.
Subject(s)
Laparoscopy , Operative Time , Pneumoperitoneum, Artificial , Robotic Surgical Procedures , Urologic Surgical Procedures , Robotic Surgical Procedures/methods , Robotic Surgical Procedures/instrumentation , Humans , Pneumoperitoneum, Artificial/methods , Laparoscopy/methods , Urologic Surgical Procedures/methods , Urologic Surgical Procedures/instrumentation , Nephrectomy/methods , Treatment Outcome , Length of Stay , Postoperative Complications/prevention & control , Postoperative Complications/etiologyABSTRACT
INTRODUCTION: The introduction of Single-Port (SP) platform opened the field to new surgical options, allowing to perform major urological robot-assisted procedures extraperitoneally and with a supine patient positioning (1-3). Nevertheless, a comprehensive description of different supine access options is still lacking (4-6). In this light, we provided a step-by-step guide of SP extraperitoneal supine access options also exploring preliminary surgical outcomes. MATERIALS AND METHODS: Transvesical access was performed by a transversal incision 3cm above the pubic bone, after the anterior abdominal sheet incision, the bladder was insufflated with a flexible cystoscope and the detrusor muscle was incised at the level of the bladder dome. Similarly, the extraperitoneal access was carried out with a 4cm incision above the pubic bone, once visualized the preperitoneal space the prevesical fat was gently spread. The Low Anterior Access was performed with a 3cm incision at the McBurney point, the abdominal muscles were then spread. A gentle dissection was used laterally to develop the retroperitoneal space. RESULTS: Overall, sixteen different procedures were performed with supine extraperitoneal access on 623 consecutive patients. No intraoperative conversions occurred. The median access time was 16 (IQR 12-21), 11 (IQR 7-14) and 14 (IQR 10-18) minutes in case of transvesical, extraperitoneal and low anterior access, respectively. Notably, 81.5 % of patients were discharged on the same day with a postoperative opioid free rate of 73%. CONCLUSION: The Atlas provides a comprehensive step-by-step guide to successfully perform all major urological SP procedures extraperitoneally and with supine patient positioning.
Subject(s)
Patient Positioning , Robotic Surgical Procedures , Humans , Supine Position , Patient Positioning/methods , Male , Robotic Surgical Procedures/methods , Female , Middle Aged , Operative Time , Aged , Laparoscopy/methods , Urologic Surgical Procedures/methods , Urologic Surgical Procedures/instrumentation , Reproducibility of ResultsABSTRACT
Robot-assisted surgery (RAS) has been integrated into clinical practice to overcome several limitations of conventional open or laparoscopic surgery. After the expiration of the long key patent period of Intuitive Surgical, various robotic systems (RSs) have been developed aiming at improving certain characteristics of the first robotic platform, the Da Vinci RS. This narrative review provides an overview of the current RSs used in urology along with the initial results from their application in urologic procedures. Nine robotic platforms are being analyzed regarding their unique characteristics as well as their efficacy, safety, feasibility, and outcomes in urologic, oncological, or non-oncological operations. The main barrier to the wide application of RAS has been the increased cost that refers to both acquisition and maintenance costs. Besides, the health inequality resulting from the lack of expert robotic surgeons and the difficulty of performing robot-assisted procedures in provincial hospitals should be overcome. However, large properly designed comparative studies are required to establish the role of newly introduced RSs. In addition, urologists should keep abreast of new developments and research in robot-assisted urologic procedures.
Subject(s)
Laparoscopy , Robotic Surgical Procedures , Urologic Surgical Procedures , Humans , Robotic Surgical Procedures/methods , Robotic Surgical Procedures/instrumentation , Laparoscopy/methods , Laparoscopy/instrumentation , Urologic Surgical Procedures/methods , Urologic Surgical Procedures/instrumentation , Urology/methods , Urology/instrumentationSubject(s)
Fascia Lata , Postoperative Complications , Registries , Suburethral Slings , Surgical Mesh , Humans , Surgical Mesh/adverse effects , Fascia Lata/transplantation , Suburethral Slings/adverse effects , Female , Postoperative Complications/etiology , Middle Aged , Urinary Incontinence, Stress/surgery , Aged , Fascia , Transplantation, Autologous , Treatment Outcome , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/instrumentationABSTRACT
BACKGROUND: Surgical interventions are more effective than nonsurgical approaches in providing a cure for stress urinary incontinence (SUI). In this study, we aimed to assess the benefits of tension-free vaginal tape (TVT) abbrevo by comparing its efficacy and complications to those of TVT obturator. METHODS AND RESULTS: 49 and 47 patients at The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University between January 2013 and December 2016 were included in the TVT-O and TVT-A groups, respectively. We evaluate the success rate and perioperative complications associated with TVT-O and TVT-A. A questionnaire that utilized the Patient Global Impression of Improvement (PGI-I) Scale was employed to assess the impact of surgery. Patients were followed up at 1 year, and 5 years after surgery. There were no statistically significant differences found in the efficacy of the TVT-A group and TVT-O group during both the one-year (p = 0.4) and five-year (p = 0.32) follow-up periods. In the period of one-year follow-up, 95.9% (n = 47) of patients in the TVT-O group and 95.8% (n = 45) of patients in the TVT-A group demonstrated improvement. During the period of five-year follow-up, 87.8% (n = 43) of patients in the TVT-O group and 93.6% (n = 44) of patients in the TVT-A group demonstrated improvement. CONCLUSIONS: Based on our findings, TVT-A and TVT-O procedures exhibited similarly high success rates and low frequencies of complications.
Subject(s)
Suburethral Slings , Urinary Incontinence, Stress , Humans , Urinary Incontinence, Stress/surgery , Female , Retrospective Studies , Middle Aged , Treatment Outcome , Follow-Up Studies , Aged , Adult , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Urologic Surgical Procedures/methods , Urologic Surgical Procedures/instrumentationABSTRACT
In the field of urology, robotic surgery has gained rapid and wide acceptance as a standard surgical approach in the majority of major surgeries over the last decade. To date, the da Vinci surgical system has been the dominant platform in robotic surgery; however, several newly developed robotic systems have recently been introduced in routine clinical practice. Of these, hinotori, the first made-in-Japan robotic system, is characterized by various unique and attractive features different from the existing system, and the use of this system has gradually increased mainly in urologic cancer surgeries, including radical prostatectomy, partial nephrectomy, radical nephrectomy, and radical nephroureterectomy. This review initially describes detailed characteristics of hinotori, then summarizes the early experience with urologic cancer surgeries using hinotori at our institution, and finally discusses the future prospects of robotic surgery using hinotori, considering problems associated with the use of this robotic system.
Subject(s)
Prostatectomy , Robotic Surgical Procedures , Urologic Neoplasms , Humans , Robotic Surgical Procedures/methods , Robotic Surgical Procedures/instrumentation , Urologic Neoplasms/surgery , Prostatectomy/methods , Prostatectomy/instrumentation , Nephrectomy/methods , Nephrectomy/instrumentation , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/methods , Nephroureterectomy/methods , MaleABSTRACT
Introduction: Robotic surgery using da Vinci surgical system has gained prominence in urology; emerging robotic platforms are expanding its applications and increasing affordability. We assess the feasibility and safety of a novel system, the Toumai® robotic system in various urological surgeries. Methods: This prospective study was conducted at the first affiliated hospital of Zhengzhou university. Twenty consecutive patients underwent renal and prostatic surgery with the Toumai. The study assessed technical feasibility (conversion rate) and safety (perioperative complications) of the procedures as primary outcomes. Secondary endpoints included key surgical perioperative outcomes: functional and oncologic results. The Endoscopic Surgical System operates within a master-slave protocol, comprising a Surgeon Console, Patient Platform, and Vision Platform. Results: Seventeen patients underwent various nephrectomy procedures and three underwent radical prostatectomy (RP). There was no conversion to alternative surgical approach; a single (Clavien-Dindo grade ≥3b) complication occurred, and no readmission was recorded within 30 days. The median operative time was 120, 140, and 210 minutes for partial nephrectomy (PN), radical nephrectomy, and RP, respectively. Off-clamp PN was performed in one case, and the warm ischemia time in the remaining two case was 18 minutes. The median docking time was 22 minutes for nephrectomy and 20 minutes for RP; no major robotic malfunction was encountered. At 3-month follow-up, no tumor recurrence was recorded, renal function was well preserved, and the continence status was satisfactory. Conclusions: We present the initial clinical utilization of an innovative robotic platform. Complex urological surgeries were successfully completed without conversions and with minimal complications. Further investigations are warranted to confirm these initial findings.
Subject(s)
Feasibility Studies , Robotic Surgical Procedures , Urologic Surgical Procedures , Humans , Robotic Surgical Procedures/methods , Robotic Surgical Procedures/instrumentation , Male , Middle Aged , Aged , Urologic Surgical Procedures/methods , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/adverse effects , Female , Prostatectomy/methods , Prostatectomy/adverse effects , Prostatectomy/instrumentation , Prospective Studies , Nephrectomy/methods , Nephrectomy/instrumentation , Adult , Treatment OutcomeABSTRACT
PURPOSE: We evaluated the performance of a new multi-degree-of-freedom articulating laparoscopic instrument, ArtiSential, and compared it with that of a straight-shaped instrument and the da Vinci surgical system, in renal surgery using porcine model. MATERIALS AND METHODS: Nine female Yorkshire pigs were equally divided into three groups. The three groups were compared at each surgical step in terms of objective and subjective parameters. RESULTS: The median operative times for renal pedicle clamping and ureter dissection were significantly shorter in ArtiSential group than robotic group (1.3 min vs. 4.7 min, p=0.002; 8.1 min vs. 11.1 min, p=0.015). The median operative time for bladder repair was significantly longer in ArtiSential group than robotic and straight-shaped groups (17.9 min vs. 5.5 min, p=0.002; 17.9 min vs. 9.3 min, p=0.026). There were no significant differences among groups in terms of blood loss or intraoperative complications. ArtiSential device was less useable for renorrhaphy (p=0.009) and bladder repair (p=0.002) compared to the robotic system. ArtiSential group was less accurate than robotic group in terms of tumor resection, renorrhaphy, and bladder repair. During ureter dissection, bladder cuff excision, and bladder repair, the surgeon experienced greater wrist discomfort but lesser back discomfort in ArtiSential group than robotic group. CONCLUSIONS: For most steps, ArtiSential performed as well as robotic and straight-shaped instruments. The development of specialized surgical techniques for ArtiSential will maximize the advantages of these instruments.
Subject(s)
Kidney , Laparoscopy , Animals , Female , Kidney/surgery , Laparoscopy/adverse effects , Laparoscopy/instrumentation , Robotics , Swine , Ureter/surgery , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/instrumentation , Models, Animal , Operative Time , Treatment OutcomeABSTRACT
OBJECTIVES: To develop and test a novel vesicoamniotic shunt (VAS) to treat fetal lower urinary tract obstruction (LUTO), decrease dislodgement and optimize shunt deployment in-vitro. METHODS: Vesicoamniotic shunt design objectives included: (1) robust and atraumatic fixation elements, (2) kink resistant conduit to adjust to fetal movement and growth, (3) one-way pressure valve to facilitate bladder cycling, and (4) echogenic deployment visualization aids. The force to dislodge the novel Vortex shunt was compared with existing commercially available shunts in a bench-top porcine bladder model. Sonographic echogenicity was evaluated with ultrasound-guided deployment, and the shunt valve pressure measured. RESULTS: A prototype novel Vortex shunt was developed using braided nitinol "umbrella-type" ends with a kink-resistant stem incorporating an internal one-way valve. The peak force required to dislodge the Vortex shunt was significantly higher than commercially available shunts (p < 0.01). Shunt deployment in the bench-top model was easily confirmed with ultrasound guidance and the brisk decompression of the inflated porcine bladder thereafter. In-vitro valve gauge pressure testing mirrored bladder pressures in human LUTO cases. CONCLUSION: In-vitro testing shows that the Vortex shunt may improve deployment, sonographic visualization, kink resistance, and dynamic size adjustment. Validation in preclinical animal models are warranted and currently underway.
Subject(s)
Equipment Design/methods , Fetal Diseases/surgery , Fetal Therapies/instrumentation , Urethral Obstruction/surgery , Urologic Surgical Procedures/instrumentation , Anastomosis, Surgical/instrumentation , Anastomosis, Surgical/methods , Animals , Female , Fetal Therapies/methods , In Vitro Techniques , Pregnancy , Swine , Urologic Surgical Procedures/methodsABSTRACT
Among the various robotic devices that exist for urologic surgery, the most common are synergistic telemanipulator systems. Several have achieved clinical feasibility and have been licensed for use in humans: the standard da Vinci, Avatera, Hinotori, Revo-i, Senhance, Versius, and Surgenius. Handheld and hands-on synergistic systems are also clinically relevant for use in urologic surgeries, including minimally invasive and endoscopic approaches. Future trends of robotic innovation include an exploration of more robust haptic systems that offer kinesthetic and tactile feedback; miniaturization and microrobotics; enhanced visual feedback with greater magnification and higher fidelity detail; and autonomous robots.
Subject(s)
Robotic Surgical Procedures/instrumentation , Robotics/history , Urologic Surgical Procedures/instrumentation , Feedback , History, 20th Century , History, 21st Century , Humans , Laparoscopy , Robotic Surgical Procedures/history , Terminology as Topic , Urologic Surgical Procedures/history , Urologic Surgical Procedures/methodsSubject(s)
Minimally Invasive Surgical Procedures , Urologic Surgical Procedures , Urology , History, 19th Century , History, 20th Century , History, 21st Century , Humans , Minimally Invasive Surgical Procedures/history , Minimally Invasive Surgical Procedures/instrumentation , Minimally Invasive Surgical Procedures/methods , Minimally Invasive Surgical Procedures/trends , Urologic Surgical Procedures/history , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/methods , Urologic Surgical Procedures/trends , Urology/trendsSubject(s)
Healthcare Disparities/statistics & numerical data , Kidney Pelvis/surgery , Robotic Surgical Procedures/standards , Urologic Surgical Procedures/standards , Age Factors , Body Size , Humans , Infant , Robotic Surgical Procedures/instrumentation , Robotic Surgical Procedures/statistics & numerical data , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/statistics & numerical dataABSTRACT
OBJECTIVE: To evaluate pain improvement and recurrent stress incontinence (SUI) following painful synthetic midurethral sling (MUS) removal. METHODS: We conducted a retrospective review of patients who underwent synthetic MUS removal at our institution from 2009-2016 for the indication of pain. We recorded sling type (transobturator vs retropubic), complete vs partial removal, and presenting symptoms. Postoperative pain improvement was categorized as resolved (pain resolved, requiring no further therapy), improved (pain less bothersome, may require further therapy), or unresolved (no/minimal improvement, requiring further management). Recurrent incontinence and further reconstructive procedures were assessed. RESULTS: 87 patients (49 complete and 38 partial removal) with pain as the primary indication for removal were included. Median age at intervention was 54 years with median follow-up of 8 months. Overall, pain improved or resolved in 78.1% of cases. Complete removal was associated with significantly greater percentage of pain resolution (63.3%) compared to partial removal (26.3%) (P = 0.002) regardless of sling type. No significant differences in recurrent SUI were noted in complete vs partial removal. Additional reconstructive procedures were performed in 28 patients, most commonly sling placement, with no significant difference in complete (20.4%) vs partial (28.9%) removal groups (P = 0.36). The overall complication rate was low (5.7%), a majority of which were transfusions (4.6%). CONCLUSION: Following MUS removal, most patients experienced resolution or improvement of pain. Complete sling removal was associated with significantly greater percentage of pain resolution compared to partial removal in both retropubic and transobturator slings. Rates of recurrent SUI and reintervention for SUI were not related to the extent of sling removal.
Subject(s)
Device Removal , Pain, Postoperative , Reoperation , Suburethral Slings , Urinary Incontinence, Stress , Device Removal/adverse effects , Device Removal/methods , Female , Humans , Middle Aged , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Pain, Postoperative/surgery , Recurrence , Reoperation/adverse effects , Reoperation/methods , Reoperation/statistics & numerical data , Suburethral Slings/adverse effects , Suburethral Slings/classification , Treatment Outcome , Urinary Incontinence/diagnosis , Urinary Incontinence/etiology , Urinary Incontinence, Stress/diagnosis , Urinary Incontinence, Stress/physiopathology , Urinary Incontinence, Stress/surgery , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/methodsABSTRACT
OBJECTIVES: To examine the durability of continent cutaneous catheterizable urinary channels (CCCC) in children and assess whether channel complications continue to arise with extended follow-up. Previous studies demonstrated that complications of CCCC cluster in the early years following surgery. METHODS: The database of a tertiary center was queried for patients≤21 years who underwent CCCC. Patients with <6 years of follow-up were excluded. Patients were invited for follow-up to assess continence. Clinic visits and hospital admissions were reviewed for channel complications requiring reoperation. Complications were analyzed against patient and channel characteristics and time since initial surgery. RESULTS: Between 1993 and 2012, a total of 120 patients underwent CCCC at a median age of 6.8(0.4-21) years and a median follow-up of 11.4(6.6-27) years. CCCC were created using the appendix, Monti channels and tapered ileal segments in 74(61.7%), 33(27.5%) and 13(10.8%), respectively. Continence relied on the extra-mural serous lined principle in 85.8% and the stoma was anastomosed to the umbilicus in 90%. Dryness with catheterization intervals of 3 hours or longer was eventually achieved in 90.8% with similar rates among different channel types (P=.149). 26(21.7%) required 42 interventions to treat channel complications with 32.5% occurring >5 years following initial surgery irrespective of the channel type (P=.978). On multivariate analysis, ileal channels had 3.372 higher odds of needing reoperation compared to appendicovesicostomy (95%CI=1.240-9.166; P = .037). CONCLUSION: A high reoperation rate is anticipated throughout the lifetime of CCCC. Appendicovesicostomy has a low complication risk relative to ileal channels.
Subject(s)
Cystostomy/methods , Postoperative Complications , Urinary Catheterization , Urinary Incontinence , Urinary Reservoirs, Continent , Urologic Surgical Procedures , Appendix/surgery , Child , Female , Follow-Up Studies , Humans , Male , Outcome and Process Assessment, Health Care , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Postoperative Complications/surgery , Plastic Surgery Procedures/methods , Reoperation/methods , Reoperation/statistics & numerical data , Urinary Catheterization/adverse effects , Urinary Catheterization/methods , Urinary Catheterization/statistics & numerical data , Urinary Incontinence/diagnosis , Urinary Incontinence/etiology , Urinary Incontinence/prevention & control , Urinary Reservoirs, Continent/adverse effects , Urinary Reservoirs, Continent/statistics & numerical data , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/methodsABSTRACT
BACKGROUND: Previously, we presented the short-term outcomes of surgeon-tailored mesh in patients with SUI undergoing TOT. In this report, we aim to highlight the two-year outcomes of surgeon tailored mesh in terms of subjective and objective cure rates, as well as late complications. METHODS: We performed a randomized, open-label comparative trial that recruited women with SUI who were scheduled to undergo TOT. Eligible patients were randomly allocated in a 1:1 ratio to receive traditional TOT mesh or surgeon-tailored polyethylene mesh. All patients were followed up for two years. RESULTS: At the end of the follow-up, there were 13 women in the traditional TOT mesh group and 14 patients in the surgeon-tailored polyethylene mesh group. Concerning the primary outcome of the present study, the cure rate was 100% in the surgeon-tailored polyethylene mesh (n = 14) and 92.9% in the traditional TOT mesh group (p = 0.39). One woman reported improved symptoms in the traditional TOT mesh group. There were no reported failures in both groups. Concerning safety, the incidence of de novo urgency was 0% in the surgeon-tailored polyethylene mesh group, compared to 7.1% in the traditional TOT mesh group (p = 0.34). None of the women in both groups reported mesh erosions, dyspareunia, or need for reoperation. CONCLUSION: Surgeon-tailored mesh for patients undergoing TOT is a cost-effective technique, which has comparable long-term outcomes, in terms of cure rate and complications, to the traditional costly meshes. Larger multicentre studies should confirm our results.
Subject(s)
Suburethral Slings , Surgical Mesh , Urinary Incontinence, Stress/surgery , Adult , Cost-Benefit Analysis , Equipment Design , Female , Follow-Up Studies , Humans , Middle Aged , Polyethylene , Surgeons , Surgical Mesh/economics , Treatment Outcome , Urologic Surgical Procedures/instrumentation , Urologic Surgical Procedures/methodsABSTRACT
Polypropylene (PPL) mesh is widely used in pelvic floor reconstructive surgery for prolapse and stress urinary incontinence. However, some women, particularly those treated using transvaginal PPL mesh placement for prolapse, experience intractable pain and mesh exposure or extrusion. Explanted tissue from patients with complications following transvaginal implantation of mesh is typified by a dense fibrous capsule with an immune cell-rich infiltrate, suggesting that the host immune response has a role in transvaginal PPL mesh complications through the separate contributions of the host (patient), the biological niche within which the material is implanted and biomaterial properties of the mesh. This immune response might be strongly influenced by both the baseline inflammatory status of the patient, surgical technique and experience, and the unique hormonal, immune and microbial tissue niche of the vagina. Mesh porosity, surface area and stiffness also might have an effect on the immune and tissue response to transvaginal mesh placement. Thus, a regulatory pathway is needed for mesh development that recognizes the roles of host and biological factors in driving the immune response to mesh, as well as mandatory mesh registries and the longitudinal surveillance of patients.
Subject(s)
Biocompatible Materials/adverse effects , Foreign-Body Reaction/etiology , Pelvic Organ Prolapse/surgery , Polypropylenes/adverse effects , Postoperative Complications/etiology , Surgical Mesh/adverse effects , Urinary Incontinence, Stress/surgery , Female , Foreign-Body Reaction/immunology , Foreign-Body Reaction/prevention & control , Gynecologic Surgical Procedures/adverse effects , Gynecologic Surgical Procedures/instrumentation , Humans , Postoperative Complications/immunology , Postoperative Complications/prevention & control , Risk Factors , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/instrumentationABSTRACT
OBJECTIVES: This study aimed to evaluate the factors affecting the treatment choice in pregnant women with symptomatic hydronephrosis. METHODS: Hospital records of pregnant women who visited our clinic due to symptomatic hydronephrosis between December 2010 and December 2020 were analysed retrospectively. Patients were divided into 2 groups: conservative and surgical (JJ stent) treatment groups. Age, gestational week, primipara, trimester, visual analogue scale (VAS), and preterm birth rates as well as clinical, laboratory, and ultrasonography findings were compared between the groups. RESULTS: The study included 227 pregnant women (conservative treatment group, 133; JJ stent group, 94). Age, gestational week, primipara, trimester, hydronephrosis side, fever, pyelonephritis, pyuria, preterm labour and abortion, as well as blood urea nitrogen, creatinine, C-reactive protein, and white blood cell levels did not differ significantly between the groups (p > 0.05). In the JJ stent group, VAS, creatinine value, culture positivity rate, degree of hydronephrosis, and renal pelvis anterior-posterior (AP) diameter were significantly higher than those in the conservative treatment group (p < 0.05). The cut-off value for renal pelvis AP diameter was 16.5 mm in the first 2 trimesters and 27.5 mm in the third trimester. CONCLUSIONS: Surgical treatment should not be delayed in pregnant women who do not respond to conservative treatment and have impaired renal function and grade 3-4 hydronephrosis. Early surgical intervention is necessary in patients with a renal pelvis AP diameter of >16.5 mm in the first 2 trimesters and >27.5 in the third trimester.
Subject(s)
Conservative Treatment , Hydronephrosis/therapy , Pregnancy Complications/therapy , Urologic Surgical Procedures , Adolescent , Adult , Clinical Decision-Making , Conservative Treatment/adverse effects , Female , Humans , Hydronephrosis/diagnosis , Hydronephrosis/physiopathology , Kidney Function Tests , Predictive Value of Tests , Pregnancy , Pregnancy Complications/diagnosis , Pregnancy Complications/physiopathology , Retrospective Studies , Stents , Symptom Assessment , Time-to-Treatment , Treatment Outcome , Urologic Surgical Procedures/adverse effects , Urologic Surgical Procedures/instrumentation , Young AdultABSTRACT
BACKGROUND: Voiding dysfunction (VD) is a potential complication after female midurethral sling operations. OBJECTIVES: Our goal was to assess the rate of obstructive VD after -transobturator tension-free tape (TOT) procedures and to find perioperative risk factors (RFs) predicting postoperative voiding problems. METHODS: We have retrospectively evaluated the perioperative data of 397 women who underwent TOT operations. Significant post-void residual (PVR) (>50 mL) was considered as the primary (objective) end point of the study, the voiding difficulty as the secondary (subjective) 1. First univariate analysis and then multivariate logistic regression were performed, with a 5% significance level. RESULTS: Significant PVR was present in 51 (12.8%) women; catheterization was needed in 21 (5.3%) and reoperation in 3 (0.8%) cases. Seventy women (17.6%) experienced postoperative voiding difficulty. Narrow vagina (<2 cm), older age >70 years, and preoperative voiding difficulty were independent RFs for significant PVR (odds ratio: 5.07, 2.14, 5.38, respectively, p < 0.05). Preoperative overactive bladder syndrome and previous pelvic organ prolapse surgery were considered independent RFs for postoperative voiding difficulty. CONCLUSIONS: Older age, narrow vagina, or preoperative voiding difficulty increases the chance for significant postoperative PVR. These patients should be chosen and counseled appropriately.